细胞治疗仪器市场基于(主要区域、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00003481
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

2021年细胞治疗仪器市场价值为151.5亿美元,预计到2031年将达到599.8亿美元。预计2023-2031年该市场的复合年增长率为15.4%。向自动化制造的转变可能仍将是细胞治疗仪器市场的一个关键趋势。

 

细胞治疗仪器市场分析

细胞疗法是将活的完整细胞注射、植入或移植到患者体内。例如,癌症患者在免疫治疗过程中被注射 T 细胞。细胞治疗仪器的交付范围从注射到使用特殊设备的手术植入。细胞疗法在许多疾病中都有应用。神经系统最重要的疾病是癌症。其他应用包括心脏病(心肌梗塞和心力衰竭)、糖尿病、骨骼和关节、遗传性疾病以及皮肤和软组织伤口。

 

细胞治疗仪器市场概况

治疗癌症最有前途的方法之一是嵌合抗原受体(CAR)T细胞疗法,每年都会进行大量的临床前和临床试验以增加其应用。经过数十年的研究,CAR-T细胞疗法将不可避免地扩大。除了自体和同种异体产品外,未来的细胞疗法还将研究新的体内CAR-T细胞基因疗法及其对血液恶性肿瘤以外适应症的疗效。 

 

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

细胞治疗仪器市场:

细胞治疗仪器市场

  • 年均复合增长率(2023 - 2031)
    15.4%
  • 2021 年市场规模
    151.5 亿美元
  • 2031 年市场规模
    599.8 亿美元

市场动态

增长动力
  • 细胞疗法制造的不断发展
未来的趋势
  • 转向自动化制造
机会
  • 发展中地区的增长机会

关键人物;主力;重要一员

  • 赛默飞世尔科技公司
  • 默克公司
  • 龙沙
  • Cytiva(GE 医疗生命科学)
  • 泰尔茂株式会社
  • BD
  • 美天旎生物技术公司
  • 干细胞科技公司
  • 赛多利斯公司
  • 丹纳赫公司(贝克曼库尔特公司)

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

Product
  • Consumables
  • Equipment
  • Systems and Software; Cell Type
Cell Type
  • Human Cells
  • Animal Cells
Process
  • Cell Processing
  • Process Monitoring and Quality Control
  • Cell Preservation
  • Distribution
  • Handling
End User
  • Research Institutes
  • Life Science Research Companies
  • Other End Users
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

 

Cell Therapy Instrument Market Drivers and Opportunities

 

Increasing Developments in Cell Therapy Manufacturing

The increasing research activities in cell therapy have led to extraordinary therapeutic developments in cell therapy instruments to treat genetic disorders and improve the immune system efficiently. Various market players provide consumables such as reagent kits and enzymes, and many companies offer instruments, equipment, and software to conduct a wide range of cell therapy processes.

Equipment use is important for producing cell therapies such as T cells, HSC, MSC, PSC, and NSC. These cell therapy products are derived from human or animal cells and thus require safe conditions from contamination. Thus, the instruments used for cell therapies help prevent contamination and allow scaling up the production. For instance, companies such as Corning Incorporated, Hitachi Chemical Advanced Therapeutics Solutions, LLC, Cytiva (General Electric Company), Thermo Fisher Scientific Inc., Invetech, and Miltenyi Biotec have introduced various instruments and consumables for cell therapy.

 

Growth Opportunities in Developing Regions– An Opportunity in the Cell Therapy Instruments Market

The biotechnology sector in Asia Pacific and Middle East is growing rapidly with the support of heavy investments and strategic developments among private and public organizations with countries in North American and European regions. For instance, in December 2019, Astellas Pharma Inc (Japan) signed an agreement to acquire Audentes Therapeutics Inc., a gene therapy company, for US$ 3 billion. Similarly, in November 2019, Fujifilm planned to invest ~US$ 120 million (13 billion yen) in gene therapy as a part of contract development and manufacturing segment of the organization. Also, the Japan Pharmaceutical Medical Device Agency (PMDA) approved two gene therapy products. The products were approved simultaneously under Sakigake designation, which is equivalent to the FDA breakthrough therapy designation and the EMA Priority Medicine (PRIME) designation and is expected to approve at least one therapy per year. Such strategic developments by the domestic players in the Asian countries for cell therapy domain are likely to increase demand for cell therapy instruments in coming future.

 

Cell Therapy Instrument Market Report Segmentation Analysis

Key segments that contributed to the derivation of the cell therapy instrument market analysis are disorder and service providers.

  • Based on products, the cell therapy instrument market is segmented into consumables, equipment, systems and software. The consumables segment held a larger market share in 2023.
  • By cell type, the cell therapy instrument market is segmented into human cells, animal cells. The thermoplastics segment held the largest share of the market in 2023.
  • By process, the cell therapy instrument market is segmented into cell processing, process monitoring and quality control, cell preservation, distribution, and handling. The cell processing segment held the largest share of the market in 2023.
  • By end users, the cell therapy instrument market is segmented into research institutes, life science research companies, other end users. The life science research companies segment held the largest share of the market in 2023.

 

Cell Therapy Instrument Market Share Analysis by Geography

The geographic scope of the cell therapy instrument market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

The US is the largest and fastest-growing market for cell therapy instruments. The market growth is attributed to increased R & D and the growing adoption of cell therapies such as gene, stem cell, and immune therapies. In addition, increasing support from the government is enhancing the growth of cell therapies, influencing the market's growth. For instance, the American Society of Gene & Cell Therapy (ASGCT), a public organization, provides memberships to scientists, physicians, professionals, and patient advocates engaged in gene and cell therapies. ASGCT aims to enhance knowledge, education, and awareness regarding the clinical application of cell and gene therapies.

 

Cell Therapy Instrument Market Report Scope

Report AttributeDetails
Market size in 2021US$ 15.15 Billion
Market Size by 2031US$ 59.98 Billion
Global CAGR (2023 - 2031)15.4%
Historical Data2021-2022
Forecast period2023-2031
Segments CoveredBy Product
  • Consumables
  • Equipment
  • Systems and Software; Cell Type
By Cell Type
  • Human Cells
  • Animal Cells
By Process
  • Cell Processing
  • Process Monitoring and Quality Control
  • Cell Preservation
  • Distribution
  • Handling
By End User
  • Research Institutes
  • Life Science Research Companies
  • Other End Users
Regions and Countries CoveredNorth America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • MERCK KGaA
  • Lonza
  • Cytiva (GE Healthcare Life Sciences)
  • Terumo Corporation
  • BD
  • Miltenyi Biotec
  • STEMCELL Technologies Inc.
  • Sartorius AG
  • Danaher Corporation (Beckman Coulter Inc.)
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

 

细胞治疗仪器市场新闻和最新动态

细胞治疗仪器市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下是足部矫形鞋垫市场的发展情况:

  • Thermo Fisher Scientific 和机器人专家 Multiply Labs 签署了一项协议,以进一步合作实现细胞治疗生产自动化。 (来源:赛默飞世尔科技,2024)。
  • 为了为下一代细胞疗法从概念到商业化提供统一的技术平台,MaxCyte 推出了 ExPERT 仪器系列。 (来源:MaxCyte,新闻稿,2019)。

 

细胞治疗仪器市场报告范围和交付成果

《细胞治疗仪器市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

  • 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,例如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports